Chimeric monoclonal antibody MOv18 IgG in ovarian cancer patients: influence of escalating doses of c-MOv18 protein

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 1996
Event	6th Conference on Radioimmunodetection and Radioimmunotherapy of Cancer - Princeton NY, United States Duration: 2 Sept 1996 → …

Conference	6th Conference on Radioimmunodetection and Radioimmunotherapy of Cancer
Country/Territory	United States
City	Princeton NY
Period	2/09/96 → …

Cite this

@conference{3eeb8a55d83c4c6aa7103704cd2b31b6,

title = "Chimeric monoclonal antibody MOv18 IgG in ovarian cancer patients: influence of escalating doses of c-MOv18 protein",

author = "C.F.M. Molthoff and W. Prinssen and \{van Hof\}, A. and P. Kenemans and \{den Hollander\}, W. and RHM Verheijen",

year = "1996",

language = "English",

note = "6th Conference on Radioimmunodetection and Radioimmunotherapy of Cancer ; Conference date: 02-09-1996",

}

Chimeric monoclonal antibody MOv18 IgG in ovarian cancer patients: influence of escalating doses of c-MOv18 protein. / Molthoff, C.F.M.; Prinssen, W.; van Hof, A. et al.
1996. Abstract from 6th Conference on Radioimmunodetection and Radioimmunotherapy of Cancer, Princeton NY, United States.

Research output: Contribution to conference › Abstract › Other research output

TY - CONF

T1 - Chimeric monoclonal antibody MOv18 IgG in ovarian cancer patients: influence of escalating doses of c-MOv18 protein

AU - Molthoff, C.F.M.

AU - Prinssen, W.

AU - van Hof, A.

AU - Kenemans, P.

AU - den Hollander, W.

AU - Verheijen, RHM

PY - 1996

Y1 - 1996

M3 - Abstract

T2 - 6th Conference on Radioimmunodetection and Radioimmunotherapy of Cancer

Y2 - 2 September 1996

ER -